AB PT cmplx conc kcentra lab
Ended Awarded
- Contract number
- SPE2DB25FP7AM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,107
Award facts
- Contract value 100% obligated
- $3,106.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,106.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents one of many delivery orders under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no set-aside designation, allowing the company to compete on its merits as a certified woman-owned small business. The specific delivery order addresses an "AB PT CMPLX CONC KCENTRA LAB" requirement, indicating procurement of pharmaceutical products or medical supplies for military healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's existing $499.99 billion Indefinite Delivery Contract with DLA under the SPE2DB program, which remains valid through November 2026. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, providing comprehensive pharmaceutical distribution services including branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to Department of Defense healthcare facilities worldwide. The company's substantial contract portfolio and established presence as a federal supplier position it as a reliable vendor for DLA's ongoing pharmaceutical procurement needs to support military health operations.
Quick answers
Who was awarded contract SPE2DB25FP7AM?
SPE2DB25FP7AM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FP7AM worth?
The government has obligated $3,107 on SPE2DB25FP7AM.
Is contract SPE2DB25FP7AM an order under another contract?
Yes. SPE2DB25FP7AM is a delivery order under SPE2DB22D9311, an indefinite delivery contract.
Was contract SPE2DB25FP7AM competed?
The extent of competition for SPE2DB25FP7AM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award